European Pharmaceutical Review

OCTOBER 12, 2023

September 2023 saw a wave of new pharmaceutical manufacturing facility expansions and launches across Europe. While the data was based on responses from 292 manufacturers across all sectors, the outcomes are applicable to pharmaceutical manufacturing. Kerry, Ireland.

Pharmaceutical manufacturing 104

Pharmaceutical manufacturing Manufacturing Pharmaceutical Pharma 104

Medico Reach

FEBRUARY 8, 2023

The Grand View Research published a report highlighting the stark growth prospects of the pharma industry. The global pharmaceutical manufacturing market stood at USD 405.52 The paradigm shift towards integrated, intelligent, and data-rich technologies is propelling the growth of medicines manufacturing.

Pharma 52

Pharma Medicine Marketing Prospecting 52

European Pharmaceutical Review

JULY 25, 2022

Consequently, pharmaceutical manufacturers risk their reputation if impersonating products fail to deliver the expected quality or health impact. These may be mislabelled or produced in fake packaging and, most dangerously, there is no regulation around their manufacture. But what exactly does this look like? .

Pharmaceutical 104

Pharmaceutical Medicine Manufacturing Pharmaceutical manufacturing 104

Pharmaceutical Technology

SEPTEMBER 13, 2022

The PharmaLex takeover will build upon the current European presence of AmerisourceBergen in pharmaceutical supply and biopharma manufacturer services expertise. This latest development will progress various AmerisourceBergen’s strategic imperatives and bolster its position to gain substantial growth prospects in the biopharma market.

Biopharma 52

Biopharma Manufacturing Pharmaceutical manufacturing Marketing 52

European Pharmaceutical Review

JULY 8, 2024

Each strain was selected to take into account: the variability of environmental and human strains in a pharmaceutical production environment strains known for their particular growth conditions, such as growth temperature, invasiveness, growth difficulties, etc (eg, Cladosporium , specific moulds, corynebacteria , Bacillus , etc).

Food and Drug Administration 95

Food and Drug Administration Pharmaceutical Pharmaceutical manufacturing Pharma 95

PM360

AUGUST 26, 2024

While some patients and insurers might be willing to pay more if the prospect of these medicines working is higher, the manufacturers might be less inclined to pursue registration if strict pricing models are in place. Bright Spots. Roche expanded its collaboration with Janssen Biotech Inc.,

Medicine 52

Medicine Food and Drug Administration Government Insurance 52

Pharmaceutical Technology

MARCH 22, 2023

In light of the Covid-19 pandemic, the war in Ukraine, and the Russian gas supply issue, several countries have called for onshoring, also referred to as reshoring; the bringing back of pharma production to locations within national borders to mitigate costs, supply issues, and concerns regarding bilateral relations.

Food and Drug Administration 105

Food and Drug Administration Manufacturing Government Pharmaceutical 105